Article

Fine balance between corneal transparency and edema

Henry Edelhauser, PhD, received the Proctor Medal and delivered the Proctor Lecture at the annual meeting of the Association for Research in Vision and Ophthalmology (ARVO) on Monday.

May 3

- Fort Lauderdale, FL - Henry Edelhauser, PhD, received the Proctor Medal and delivered the Proctor Lecture at the annual meeting of the Association for Research in Vision and Ophthalmology (ARVO) on Monday. Dr. Edelhauser, director of research at the department of ophthalmology at Emory University, was honored with ARVO's highest honor for his groundbreaking work on the physiology of the corneal endothelium and for elegant translational research from basic science to clinical applications.

His lecture focused on the fine balance the eye maintains between corneal transparency and edema. He described the substances that affect the corneal endothelial cells, which maintain transparency, and those substances that contribute to the breakdown of the cells. Some substances that result in endothelial cell decompensation are solutions with low calcium levels, ph below 6.8 or above 8.2, solutions with low osmolarity, toxic detergents, and diseases such as Fuchs' dystrophy.

"Corneal transparency is an interesting phenomenon. The corneal endothelium is a very important tissue in maintaining corneal transparency by maintaining its barrier and the metabolic pump. Loss of either of the metabolic pump or the barrier function results in corneal edema and loss of transparency," Dr. Edelhauser said.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.